Danny Ben-Avraham received his Ph.D. from the Hebrew University. After completion of his degree, he spent three years as a research fellow in the institute for Aging Research at the Albert Einstein College of Medicine (NY) where his research focus was the human genome and epigenome and its impact on aging and longevity. Prior to joining the Center, Danny worked at Proteologics Ltd., a biopharmaceutical company that specializes in the ubiquitin system, as the Head of Bio & Cheminformatics group. In this role, he built expert systems, used statistical methods and advanced techniques in computer-aided drug design such as QSAR, Pharmachophores, Docking and homology modeling. Previously, he worked at Quark Biotech Inc., as an Advanced Annotation team leader in the Bioinformatics group, and at Comverse Technology, Inc. as a programmer and activity leader.
*Incumbent of the David and Stacey Cynamon Reaserch fellow Chair in Genetics and Personalized Medicine